Inventors:
Anindita Ganguly - Hawthorne NY, US
Jennifer Iaci - Boonton NJ, US
Thomas Parry - Hellertown PA, US
International Classification:
A61K 38/18
Abstract:
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.